Evidence map›Paper›PMID 27229136›Full record

ArticleNucleic acids research2016

G9a promotes proliferation and inhibits cell cycle exit during myogenic differentiation.

Vinay Kumar Rao, Jin Rong Ow, Shilpa Rani Shankar, Narendra Bharathy, Jayapal Manikandan, Yaju Wang, Reshma Taneja

Open access · goldAbstract read
In one paragraph

Article in Nucleic acids research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed
3.0field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Targets of histone H3 lysine 9 methyltransferases.Frontiers in cell and developmental biology · 2022
    Review
  18. An interplay between BRD4 and G9a regulates skeletal myogenesis.Frontiers in cell and developmental biology · 2022
    Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Vinay Kumar RaoDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore.
Jin Rong OwDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore.
Shilpa Rani ShankarDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore.
Narendra BharathyDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore.
Jayapal ManikandanNanoString Technologies, 530 Fairview Ave N, Suite 2000 Seattle, WA, USA.
Yaju WangDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore.
Reshma TanejaDepartment of Physiology, Yong Loo Lin School of Medicine, National University of Singapore, 117597, Singapore phsrt@nus.edu.sg.
National University of Singapore · SGNanostring Technologies (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Differentiation of skeletal muscle cells, like most other cell types, requires a permanent exit from the cell cycle. The epigenetic programming underlying these distinct cellular states is not fully understood. In this study, we provide evidence that the lysine methyltransferase G9a functions as a central axis to regulate proliferation and differentiation of skeletal muscle cells. Transcriptome analysis of G9a knockdown cells revealed deregulation of many cell cycle regulatory genes. We demonstrate that G9a enhances cellular proliferation by two distinct mechanisms. G9a blocks cell cycle exit via methylation-dependent transcriptional repression of the MyoD target genes p21(Cip/Waf1) and Rb1. In addition, it activates E2F1-target genes in a methyltransferase activity-independent manner. We show that G9a is present in the E2F1/PCAF complex, and enhances PCAF occupancy and histone acetylation marks at E2F1-target promoters. Interestingly, G9a preferentially associates with E2F1 at the G1/S phase and with MyoD at the G2/M phase. Our results provide evidence that G9a functions both as a co-activator and a co-repressor to enhance cellular proliferation and inhibit myogenic differentiation.

Indexed as

Cell CycleCell DifferentiationMuscle DevelopmentAnimalsCell LineCell ProliferationE2F1 Transcription FactorGene Expression RegulationGene Knockdown TechniquesHistone-Lysine N-MethyltransferaseHistonesLysineMethylationMice, Inbred C57BLMyoblastsMyoD ProteinE2F1 Transcription FactorG9a protein, mouseHistone-Lysine N-MethyltransferaseHistonesLysineMyoD Proteinp300-CBP-Associated Factorp300-CBP Transcription Factors

Identifiers

PMID27229136
PMCPMC5041453
OpenAlexW2404028298

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.